Valuation Alkem Laboratories Limited Bombay S.E.

Stocks

Delayed Bombay S.E. Other stock markets 09:50:36 30/06/2026 +03			5-day change	1st Jan Change
5,494.15 ^INR	+1.43%		+1.53%	-0.20%

06-02	Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350	CI
06-02	Alkem Laboratories Shows Strong Moves But Weak Follow-Through

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	331,171	432,909	406,055	590,890	583,680	647,624	-	-
Change	-	30.72%	-6.2%	45.52%	-1.22%	10.96%	-	-
Enterprise Value (EV) ¹	328,603	433,805	393,853	587,236	578,678	632,481	617,149	603,569
Change	-	32.02%	-9.21%	49.1%	-1.46%	9.3%	-0.38%	-2.2%
P/E	20.9x	26.3x	41.3x	32.9x	27x	27.5x	27.6x	24x
PBR	4.49x	5.01x	4.49x	5.73x	4.87x	4.58x	4.19x	3.7x
PEG	-	6.89x	-1x	0.4x	1.3x	4.37x	-3.79x	1.6x
Capitalization / Revenue	3.74x	4.07x	3.5x	4.66x	4.5x	4.31x	3.91x	3.55x
EV / Revenue	3.71x	4.08x	3.4x	4.64x	4.46x	4.3x	3.73x	3.31x
EV / EBITDA	16.9x	21.1x	24.5x	26.2x	23x	21x	18.1x	15.5x
EV / EBIT	19.7x	24.8x	30.3x	30.2x	26.9x	24.1x	20.8x	17.7x
EV / FCF	30.4x	55.4x	27.1x	33.3x	45.3x	42.8x	34.1x	29x
FCF Yield	3.29%	1.81%	3.69%	3%	2.21%	2.33%	2.94%	3.45%
Dividend per Share ²	28	34	25	40	45	53	51.49	56.66
Rate of return	1.01%	0.94%	0.74%	0.81%	0.92%	1%	0.95%	1.05%
EPS ²	132.6	137.6	82.31	150.2	181.1	192.5	196	225.4
Distribution rate	21.1%	24.7%	30.4%	26.6%	24.8%	27.5%	26.3%	25.1%
Net sales ¹	88,650	106,342	115,993	126,676	129,645	147,123	165,551	182,526
EBITDA ¹	19,424	20,529	16,094	22,455	25,122	30,052	34,136	38,956
EBIT ¹	16,678	17,490	12,990	19,462	21,550	26,232	29,663	34,038
Net income ¹	15,850	16,456	9,842	17,958	21,655	23,018	23,923	27,679
Net Debt ¹	-2,568	896.1	-12,202	-3,654	-5,003	-1,094	-30,475	-44,054
Reference price ²	2,769.80	3,620.70	3,396.10	4,942.00	4,881.70	5,416.50	5,416.50	5,416.50
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	5/25/21 A	5/13/22 A	5/19/23 A	5/29/24 A	5/29/25 A	5/28/26 A	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.95x	13.06x	26.6x	0.55%	1,097B
JOHNSON & JOHNSON	27.63x	6.35x	17.27x	2.06%	622B
ABBVIE INC.	31.37x	7.5x	15.34x	2.72%	449B
ROCHE HOLDING AG	18.05x	4.48x	11.03x	2.96%	334B
ASTRAZENECA PLC	23.74x	4.94x	14.01x	1.76%	294B
NOVARTIS AG	21.75x	5.59x	13.5x	2.83%	286B
NOVO NORDISK A/S	13.9x	5.17x	10.63x	3.6%	213B
AMGEN INC.	23.5x	6.26x	11.01x	2.8%	195B
GILEAD SCIENCES, INC.	-45.11x	5.46x	30.35x	2.57%	157B
Average	16.75x	6.53x	16.64x	2.43%	405.19B
Weighted average by Cap.	24.79x	8.05x	18.55x	1.96%